Your Article Summary
(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Medtronic Starts “VITALITY,” a Post-Market Study of the Talent Abdominal Stent Graft
Medtronic, 01/27/09
Medtronic, Inc. (NYSE: MDT), reported the first enrollment in VITALITY1, the company’s post-market clinical study of its Talent Abdominal Stent Graft for the endovascular repair of abdominal aortic aneurysms.
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Go Go Generics
PharmExec, 12/18/09
MediciNova and Avigen Stockholders Approve Merger
Avigen, 12/18/09
Almirall and Forest Laboratories to Expand Respiratory Collaboration with LAS100977
Forest Laboratories, 12/18/09
Article Search
Sponsor


See Latest Articles


